𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor–II in Wilms tumor

✍ Scribed by Naoki Watanabe; Hisaya Nakadate; Masayuki Haruta; Waka Sugawara; Fumiaki Sasaki; Yukiko Tsunematsu; Atsushi Kikuta; Masahiro Fukuzawa; Hajime Okita; Jun-ichi Hata; Hidenobu Soejima; Yasuhiko Kaneko

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
202 KB
Volume
45
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

We evaluated the WT1 and IGF2 status and performed chromosome and/or comparative genomic hybridization analysis in 43 tumor samples from patients with Wilms tumor. On this basis, we classified them into 4 groups: WT1 abnormality, loss of heterozygosity (LOH) of IGF2, loss of imprinting (LOI) of IGF2, and retention of imprinting (ROI) of IGF2, which were seen in 12%, 30%, 16%, and 42% of the tumors, respectively. Patients in the LOI group were older than those in other groups (P < 0.01), and tumors in the WT1 group had fewer cytogenetic changes than did those in the other groups (P < 0.01). It was found that 11q− and +12 were more frequent in the LOI group than in the WT1+LOH+ROI group (P < 0.01 and P < 0.01). There was no difference in the incidence of 16q− between the LOI group and the other groups; however, when we excluded 16 tumors with LOH on 11p15, 16q− tended to be more frequent in the LOI group than in the WT1+ROI group (P = 0.06). The association of 11q− or +12 with LOI of IGF2 found in the present study suggests that many tumors with no WT1 abnormalities need overexpression of IGF2 together with biallelic inactivation of the tumor‐suppressor gene on 11q and/or overexpression of growth‐promoting genes on chromosome 12. The 11q gene may code for one of the proteins that constitute a CTCF insulator complex, and its mutation, deletion, or haploinsufficiency may cause insulator abnormalities that might lead to LOI of IGF2. © 2006 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Association of chromosome arm 16q loss w
Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor–II in Wilms tumor
✍ Stephanie K. Mummert; Victor A. Lobanenkov; Andrew P. Feinberg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

## Abstract The most common known molecular defect in Wilms tumor (WT) of the kidney, the most frequent solid tumor of childhood, is loss of imprinting (LOI) of the insulin‐like growth factor–II gene (__IGF2__), which involves activation of the normally silent maternal allele of the gene and hyperm

Loss of 11q and 16q in Wilms tumors is a
Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis
✍ Stefanie Wittmann; Birgit Zirn; Muhannad Alkassar; Peter Ambros; Norbert Graf; M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 2 views

## Abstract Allele loss of chromosome arms 11q and 16q in Wilms tumors has been associated with different clinical parameters in prior studies. To substantiate these findings in a large collection of tumors treated according to the GPOH/SIOP protocol and to narrow down critical regions, we performe

Allele loss in Wilms tumors of chromosom
Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlates with clinicopathological parameters
✍ Barbara Klamt; Michael Schulze; Claudia Thäte; Jaroslav Mares; Peter Goetz; Roma 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

An extended analysis for loss of heterozygosity (LOH) on eight chromosomes was conducted in a series of 82 Wilms tumors. Observed rates of allele loss were: 9.5% (1p), 5% (4q), 6% (6p), 3% (7p), 9.8% (11q), 28% (11p15), 13.4% (16q), 8.8% (18p), and 13.8% (22q). Known regions of frequent allele loss

Clinicopathological characteristics of c
Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2
✍ Jun-ichi Sasaki; Fumio Konishi; Yutaka J. Kawamura; Toshihiro Kai; Osamu Takata; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 98 KB 👁 2 views

## Abstract Loss of imprinting (LOI), the biallelic expression of an imprinting gene, of insulin‐like growth factor 2 (__IGF2__) has been reported to be associated with colorectal carcinogenesis because of its high prevalence in normal colorectal mucosa as well as cancerous tissue in patients with

Loss of imprinting of the insulin-like g
Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines
✍ Takao Ooasa; Hidenori Karasaki; Hiroaki Kanda; Kimie Nomura; Tomoyuki Kitagawa; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

We investigated expression of insulin-like growth factor II (Igf2) in primary cultured hepatocytes, liver epithelial (LE) cell lines derived from normal hepatocytes, and hepatocellular carcinoma (HCC) cell lines from crosses between C3H/HeJ (C3H) and Mus musculus molossinus mice (MSM). Igf2 mRNA was

Loss of imprinting and abnormal expressi
Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer
✍ Qing-Song Zuo; Ronglin Yan; Dian-Xu Feng; Ronghua Zhao; Chao Chen; Yi-Ming Jiang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

## Abstract This study examined the frequency of loss of imprinting (LOI) and expression of the insulin‐like growth factor 2 (__IGF2__) gene, and their relationship to selected clinical and pathological factors, in a well defined series of 90 Chinese patients with gastric cancer (GC) and 90 matched